DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology
    This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses.
    We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail.
    First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision.
    Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal.
    And, of course, Chris Newmarker, executive editor of Mass Device, delivers this week’s Newmarker’s Newsmakers including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott.
    Finally, don’t forget to join us on Clubhouse for DeviceTalks Weekly Live at 1 pm ET on Wed.
    1 hr 5 min
  • CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids
    Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity.
    In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the US and around the world.
    He also shares what’s next for the company which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health.
    While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including the loss of loved ones to COVID-19 and other diseases.
    CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medical device industry.
    We’ll also hear from our sponsor, PackWorld USA, a leader in heat sealing technology.
    Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker's Newsmakers including news from ThermoFisher Scientific, Second Sight, Boston Scientific and Medtronic.
    Senior Editor Danielle Kirsh also joins us to review her overview on how top medical device are faring a year after the start of the pandemic. https://www.medicaldesignandoutsourcing.com/how-big-medtech-fared-during-a-year-of-covid-19/
    Subscribe now on all major podcast channels.
    1 hr 18 min
  • J&J’s McEvoy talks vaccines, digital surgery, and the power of innovation; Stryker’s Murray sees 3D
    HAPPY BIG 5-0!!
    This week’s is our 50th DeviceTalks Weekly Podcast, and we’re going to celebrate!
    Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson, makes her DeviceTalks Weekly debut.
    In this update, McEvoy delivers great insights on several areas of interest including:
    • COVID-19’s impact on J&J in the past, and what changes may remain in the future.
    • J&J’s far-ranging digital surgery portfolio could bolster many of its specialties.
    • How the company uses its innovation network to accelerate development
    • Why she’s bullish on the future of eye care.
    • How the company will prepare for future challenges.
    We also talk with Naomi Murray, Director of Advanced Operations-Additive Technology at Stryker about her almost predestined path to join the orthopedics leader.
    She’ll be leading the March 23 discussion on Additive Manufacturing at DeviceTalks Tuesday. Register at DeviceTalks.com.
    Colleague Lisa Eitel, executive editor of Design World, crashes the party to tell us about her upcoming Women in Engineering webcast. Register for that discussion at https://www.designworldonline.com/design-world-online-events-and-webinars/
    Finally, Chris Newmarker delivers some good news and bad Newmarker's Newsmakers from the digital pages of MassDevice, Medical Design & Outsourcing, and other sites. Companies highlighted include Frequency, Medtronic, Theranos, GE Healthcare, DJO and Stryker
    Subscribe now on any major podcast channel. Google. Apple. Spotify. Amazon, etc.
    1 hr 15 min
  • CEO Shacey Petrovic shares how Insulet is convincing people with diabetes to swap shots for `Pods
    Shacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day.
    In this interview, Petrovic explains why research wasn't for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot.
    In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday's DeviceTalks Clubhouse series.
    Finally, Chris Newmarker delivers the big news of the week involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.
    57 min
  • Arrigato Mr. Surgical Roboto – Ferré, Usen and Fernando steer Medtech toward digital surgery
    In the longest DeviceTalks Weekly Podcast ever created, the leaders of three digital surgery companies – two with robotic components – explain where their systems will fit into Medtech future.
    Anthony Fernando, the CEO of newly names Asensus (formerly Transenterix) maps out the company’s future in delivering a better solution for laproscopic procedure.
    Todd Usen – a veteran of big Medtech companies – explains why he swapped P&Ls for just the L’s of a start-up Active Surgical, which is building a surgical mapping tool that could help surgeons avoid deadly errors.
    Finally, Maurice Ferre,’ founder of orthopedic pioneer MAKO Surgical, says Memix is positioned to grab the opportunity being missed by larger medtech companies building their own robotic systems. He also walks us through the dinner where Stryker CEO Kevin Lobo made an offer that MAKO did not refuse.
    MassDevice Honcho Chris Newmarker delivers his Newmarker’s Newsmakers featuring stories from Medtronic, Hillrom, BardyDx, Boston Scientific, Lumenis, and Memic Innovative Surgery.
    Associate editor Sean Whooley joins the show take on Chris in Robot Surgery Name Jeopardy!!
    You’ll also hear from our great sponsors Packworld USA, PSN Labs and Finnegan.
    1 hr 46 min
  • Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently
    Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant overhaul of medtech’s largest player.
    In our closing keynote conversation, Martha says the company is clearing minor COVID-19 bump and sees open road for the company to continue to grab share from competitors.
    Martha details what products are gaining the most traction while also identifying those that still have some ground to gain.
    We also discuss:
    - When it may bring its renal denervation project to the FDA
    - Why the surgical robotic Hugo system will be worth the wait (and why development has taken more than a decade)
    - Whether or not Medtronic will collaborate more with private equity firms, early-stage incubators and maybe even SPACs?
    - What will the company’s acquisition strategy look like in 2021. And why.
    - Why the price-cutting for drug-eluting stents may represent an opportunity for Medtronic’s more innovative products.
    Opening our episode is an important interview with Duke Rohlen, CEO of Ajax Health.
    Rohlen, a company builder who has generated more than a $1 billion in selling his companies to larger strategics, explains how his work with KKR creates more fertile opportunity for innovative medtech start-ups.
    Rohlen introduces us to Zeus Health, a new KKR-partnership that will be used to give medtech start-up CEOs the capital – and options – they need to build the next generation of innovative medtech products.
    Rohlen also breaks down the three critical stages of start-up development.
    Chris Newmarker, executive editor of Life Sciences, delivers his #NewmarkersNewsmakers.
    Topping the list is Asensus, the recently renamed Transenterix followed by Becton Dickinson announcing a new deal with Scanwell, former Verb CEO Scott Huennekens leading a new SPAC, Abiomed CEO Michael Minogue leading AdvaMed and PavidMed spinning of a subsidiary, Lucid Medical.
    Paul Heney of Design World, a sister publication to MassDevice, also invites medtech engineers to submit their best work to the R&D 100 contest for most innovative creations. Find out more at https://www.rd100conference.com/
    1 hr 22 min
  • Tale of Two CEOs - How Tim Herbert led Inspire to an IPO; Where Rob Bodor wants to take Protolabs
    Inspire Medical CEO Tim Herbert never set out to be a CEO.
    Yet, he spun a promising #sleepapnea technology out of Medtronic. He then assembled a team that helps hard-to-treat apnea patients live healthier lives through better sleep.
    Oh, and the electrical engineer turned startup-CEO took the medtech public in 2018.
    Listen to this episode to hear how Inspire management worked with the FDA, payers and public investor to build a burgeoning neuromed giant.
    We also talk to Rob Bodor, the incoming CEO at Protolabs. Bodor succeeds the highly successful Vicki Holt who built the manufacturing company into an acquisitive powerhouse. Bodor shares what's next for the company.
    Co-costs Chris Newmarker, executive editor of life sciences at MassDevice, unveils this week's Newmarker's Newsmakers featuring news from Thermo Fisher Scientific, Mainstay Medical, Theranos, Butterfly Networks and Zimmer Biomet's Newco.
    Subscribe today on your major podcast apps - Apple, Amazon, Spotify.
    1 hr 3 min
  • Dean Kamen eyeing 3D organs; Todd Pope talks clean air; Joe Mullings says Medtech’s time is now
    Please lift this jam-packed episode with your legs, not your back.
    *We'll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech.
    *Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID
    *Joe Mullings of the Mullings Group explains why now is the best time to be in the Medtech industry.
    Chris Newmarker, executive editor of life sciences, delivers a murderers row of #newmarkersnewsmakers with Philips, Medtronic, iRyhthm, Canary Medical and Apollo Endosurgery.
    To hear Dean Kamen's entire interview with my Design World colleague Paul Heney go here. It's free and outstanding! https://gateway.on24.com/wcc/eh/2927718/lp/2870030/engineering-robots-for-the-future
    Thanks for subscribing!
    1 hr 23 min
  • Can Corza bust up Medtech’s surgical supply monopolies? Why Zimmer’s spin out is only the beginning
    In this week’s episode learn how Greg Lucier, executive chairman of Corza Medical, intends to use his experience and GTCR's capital to build a surgical supply company that he says will challenge medtech's (almost) monopolies.
    Corza's strategy rests upon customization, a high level of digitalization and customer service. Lucier also explains how working on the railroads led to his joining the medtech industry.
    Chris Newmarker, executive editor of life science, interviews Rich Newitter, Managing Director, Medical Supplies and Devices, about Zimmer Biomet’s decision to spin off its dental and spinal business into a new company.
    Newitter also explains how Zimmer Biomet is grabbing share in the orthopedic space and building an enviable portfolio of digital sensors and systems.
    Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others.
    Subscribe now on your favorite podcast player!
    57 min
  • CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4
    In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream.
    Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the groups goals and invites entrepreneurs of color to apply for the group’s Pitch Contest.
    The deadline is Feb. 5. Go to medtechcolor.org for more information.
    Truist Security Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies.
    Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again.
    Pharma Editor Brian Buntz returns to the podcast to tell his story of his 10 days wearing a continuous glucose monitor from Dexcom.
    Buntz wrote about the experience here, but he shares more details on the podcast. https://www.drugdeliverybusiness.com/how-cgms-can-inspire-lifestyle-changes/
    Finally, Chris Newmarker, executive editor of life sciences, delivers his #newmarkersnewsmakers featuring Titan, Mylan, Zimmer Biomet, and Butterfly.
    1 hr 1 min